Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

NCT05520749 · clinicaltrials.gov ↗

COMPLETED

Status

215

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Dysplasia

Interventions

DRUG: Luspatercept

Sponsor

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Collaborators

[object Object]